on 19 Jul 2023
Last Applicant/ Owned by
VERTEX PHARMACEUTICALS INCORPORATED
50 Northern AvenueBoston MA 02210
US
Serial Number
2153080 filed on 09th Nov 2021
Registration Number
TMA1191060 registered on 19th Jul 2023
Registration expiry Date
09th Nov 2031Correspondent Address
1400 - 340 ALBERT STREETOTTAWA
ONTARIO
CA
K1R0A5
Trademark usage description
pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia and sickle cell disease.11
2153080
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 27 on 28th Mar 2023 | Approval Notice Sent |
Submitted for opposition 26 on 28th Mar 2023 | Approved |
Submitted for opposition 22 on 22nd Mar 2023 | Search Recorded |
Submitted for opposition 256 on 10th Oct 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 01st Mar 2022 | Agent Changed |
Submitted for opposition 257 on 09th Dec 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 08th Dec 2021 | Created |
Submitted for opposition 31 on 08th Dec 2021 | Formalized |
Submitted for opposition 30 on 09th Nov 2021 | Filed |
Submitted for opposition 228 on 09th Nov 2021 | International Registration |